Her weight began to creep up in her early 20s, and no matter how much she restricted herself, ate clean, and worked out, no matter how many times the scale shifted a few pounds here and there, the weight always came back in surplusand the debilitating preoccupation with food never stopped
For patients with a hungry brain, switching to dual agonists such as tirzepatide (commercially known as Mounjaro), which targets two digestive hormones, GLP-1 and glucose-dependent insulinotropic peptide (GIP) may be useful
Documentation of symptom onset, severity, associated factors, and temporal relationship to medication dosing helps clinicians determine appropriate evaluation and management
Our GLP-1 weight loss system supports the person taking it